Staphylococcal Infections
Showing 1 - 25 of 9,611
Skin Infection, Staphylococcal Infections, Staphylococcus Aureus Infection Trial (Clindamycin, Standard of care)
Not yet recruiting
- Skin Infection
- +2 more
- Clindamycin
- Standard of care
- (no location specified)
Jun 15, 2023
Antistaphylococcal Betalactam and Emergence of Resistance
Completed
- Bacterial Resistance
- Methicillin-Sensitive Staphylococcus Aureus Infection
-
Nancy, Lorraine, FranceLefevre
Jul 1, 2023
Bacteremia Due to Methicillin Susceptible Staphylococcus Aureus Trial in Paris (Cloxacillin, Cefazolin)
Recruiting
- Bacteremia Due to Methicillin Susceptible Staphylococcus Aureus
-
Paris, FranceFrançois-Xavier Lescure
Dec 7, 2022
Staphylococcus Aureus, Microbial Colonization, Neonatal Infection Trial in Baltimore (nasal microbiota transplant (NMT),
Not yet recruiting
- Staphylococcus Aureus
- +2 more
- nasal microbiota transplant (NMT)
- Placebo
-
Baltimore, MarylandJohns Hopkins University
Jan 12, 2023
Complicated Staphylococcus Aureus (S. Aureus) Infections (CSAI) Trial in Basel (FLU or CZO as continuous infusion, standard FLU
Not yet recruiting
- Complicated Staphylococcus Aureus (S. Aureus) Infections (CSAI)
- FLU or CZO as continuous infusion
- standard FLU or CZO intermittent bolus administration
-
Basel, SwitzerlandUniversity Hospital Basel, Division of Internal Medicine
Dec 14, 2022
Recurrent S. Aureus Infections in Osteoarticular Infections
Recruiting
- Staphylococcus Aureus Infection
- Bone and Joint Infection
- relapse due to S. aureus
-
Lyon, FranceHospices Civils de Lyon
Jan 19, 2022
Latent Tuberculosis, Staphylococcus Aureus Trial in Malmö (No intervention is part of the study protocol)
Recruiting
- Latent Tuberculosis
- Staphylococcus Aureus
- No intervention is part of the study protocol
-
Malmö, SwedenSkåne University Hospital
Oct 24, 2022
Catheter Bacteremia, Staphylococcus Aureus Infection Trial (Dalbavancin, Standard of care)
Withdrawn
- Catheter Bacteremia
- Staphylococcus Aureus Infection
- Dalbavancin
- Standard of care
- (no location specified)
Jul 19, 2022
Staphylococcus Aureus Bacteremia, Staphylococcus Aureus Endocarditis Trial in Philadelphia (Oritavancin Injection)
Withdrawn
- Staphylococcus Aureus Bacteremia
- Staphylococcus Aureus Endocarditis
- Oritavancin Injection
-
Philadelphia, PennsylvaniaClinical Trials Unit. University of Pennsylvania
Mar 28, 2022
Nasal Decolonization of Staphylococcus Aureus Trial in Uppsala (Vehicle gel, 4 + 4 applications or 4 + 2 applications, LTX-109
Completed
- Nasal Decolonization of Staphylococcus Aureus
- Vehicle gel, 4 + 4 applications or 4 + 2 applications
- +2 more
-
Uppsala, SwedenClinSmart Sweden AB
May 25, 2023
Staphylococcus Aureus Bacteremia, Staphylococcus Aureus Septicemia, Staphylococcal Sepsis Trial in Montreal (Ertapenem, Placebo)
Not yet recruiting
- Staphylococcus Aureus Bacteremia
- +3 more
- Ertapenem
- Placebo
-
Montreal, Quebec, CanadaMcGill University Health Centre (Royal Victoria Hospital and Mon
Feb 21, 2022
Staphylococcus Lugdunensis Prosthetic Joint Infection
Completed
- Staphylococcal Infections
- Prosthetic Joint Infection
- Prothestic joint infection due to Staphylococcus lugdunensis
-
Lyon, FranceHospices Civils de Lyon
Jun 15, 2021
Staphylococcus Aureus Bacteremia, Infective Endocarditis Trial (Echocardiography evaluation)
Not yet recruiting
- Staphylococcus Aureus Bacteremia
- Infective Endocarditis
- Echocardiography evaluation
- (no location specified)
May 7, 2023
Diabetic Foot Ulcer, Pseudomonas Aeruginosa Infection, Staphylococcus Aureus Infection Trial in Jerusalem, Tel Aviv (TP-102)
Recruiting
- Diabetic Foot Ulcer
- +3 more
- TP-102
-
Jerusalem, Israel
- +1 more
Jun 17, 2022
Staphylococcus Aureus Infection Trial in United States (Povidone-Iodine Topical Ointment, Standard Care)
Enrolling by invitation
- Staphylococcus Aureus Infection
- Povidone-Iodine Topical Ointment
- Standard Care
-
Atlanta, Georgia
- +4 more
May 16, 2022
Diabetic Foot, Staphylococcal Infections Trial in France (Topical anti-Staphylococcus bacteriophage therapy, Topical
Not yet recruiting
- Diabetic Foot
- Staphylococcal Infections
- Topical anti-Staphylococcus bacteriophage therapy
- Topical placebo corresponding to anti-Staphylococcus bacteriophage therapy
-
Bordeaux, France
- +8 more
Feb 2, 2022
Delta-haemolysin Production Deficiency in Staphylococcus Aureus
Recruiting
- Bone and Joint Infection
- Staphylococcus Aureus
- Delta-haemolysin
-
Lyon, FranceHospices Civils de Lyon
Jan 7, 2022
Staphylococcus Aureus Infection Trial in Shanghai (9MW1411 injection, 9MW1411 injection )
Completed
- Staphylococcus Aureus Infection
- 9MW1411 injection
- 9MW1411 injection placebo
-
Shanghai, Shanghai, ChinaHuashan Hospital Fudan University
Jun 14, 2022
Staphylococcus Aureus Bacteremia, Staphylococcus Aureus Septicemia, Sepsis Bacterial Trial (PET/CT)
Not yet recruiting
- Staphylococcus Aureus Bacteremia
- +6 more
- PET/CT
- (no location specified)
Apr 29, 2022
Probability of Target Attainment With Standard Intermittent
Completed
- Staphylococcus Aureus Infection
- Blood samples for the measurement of the concentration of cefazolin
- +4 more
-
Basel, SwitzerlandUniversity Hospital Basel, Division of Internal Medicine
Mar 28, 2022
Staphylococcus Aureus Trial in Belcamp, Lutherville-Timonium (Targeted gown and glove use)
Completed
- Staphylococcus Aureus
- Targeted gown and glove use
-
Belcamp, Maryland
- +1 more
Apr 8, 2022
Staphylococcus Aureus Trial in Montpellier (PET/CT Positron emission tomography (PET) using small radiotracers, a special camera
Recruiting
- Staphylococcus Aureus
- PET/CT Positron emission tomography (PET) using small radiotracers, a special camera and a computer to evaluate organ and tissue functions
- Patients' routine care with performance of explorations based on anamnesis and clinical symptoms
-
Montpellier, FranceChu Gui de Chauliac
Dec 20, 2021
Staphylococcal Infection, Streptococcal Infection Trial in Bron (PRIVIGEN (CSL Behring), Albumin)
Withdrawn
- Staphylococcal Infection
- Streptococcal Infection
- PRIVIGEN (CSL Behring)
- Albumin
-
Bron, FranceHôpital Femme Mère Enfant
Apr 28, 2021
Hematogenously Acquired Staphylococcus Aureus Osteomyelitis, Bone Infection, Osteomyelitis Trial in Houston (Ceftaroline
Completed
- Hematogenously Acquired Staphylococcus Aureus Osteomyelitis
- +2 more
- Ceftaroline Fosamil
-
Houston, TexasTexas Children's Hospital
Oct 5, 2021
Meticillin-susceptible Staphylococcal Infective Endocarditis:
Completed
- Infectious Disease
- Endocarditis
-
Metz-Tessy, FranceCentre Hospitalier Annecy Genevois
Jul 21, 2022